Immucell ICCC
NASDAQ ICCC
$9.91 +0.07 (+0.71%)
At close: Sep 9, 2026 · 4:00 PM EDT

Immucell (ICCC) Net Margin (2010 - 2026)

Immucell's (ICCC) quarterly Net Margin came in at 25.53% in Q2 2026, up 1774.0% on a YoY basis from 1.36% in Q2 2025, and up 174.27% quarter-over-quarter from 34.38% in Q4 2025.

Analysis

Immucell (ICCC) Net Margin (2010 - 2026) Analysis & Trends

Immucell (ICCC) has reported Net Margin for 17 consecutive years, with 25.53% the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Net Margin rose 1774.0% year-over-year to 25.53%; the trailing twelve-month figure through Jun 2026 stood at 1.59% (down 945.0% YoY), and the FY2025 full-year result was 2.94%, up 346.0% from the prior year.
  • Net Margin grew to 25.53% in Q2 2026 per ICCC's latest filing, from 34.38% in the prior quarter.
  • Across five years, Net Margin topped out at 25.53% in Q2 2026 and bottomed at 67.17% in Q1 2023.
  • Historically, Net Margin has averaged 12.36% across 5 years, with a median of 12.67% in 2022.
  • The sharpest annual moves came in 2023 and 2024: Net Margin slumped 7943 bps in 2023, then surged 6114 bps in 2024.
  • Over 5 years, Net Margin stood at 29.1% in 2022, then surged by 40 bps to 17.42% in 2023, then surged by 172 bps to 12.58% in 2024, then tumbled by 373 bps to 34.38% in 2025, then surged by 174 bps to 25.53% in 2026.
  • According to Business Quant data, Net Margin over the past three periods registered 25.53%, 34.38%, and 2.54% for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Idexx Laboratories 40.69 Bn 40.49 Bn 779.09 Mn 27.82%
2 Zoetis 30.63 Bn 28.95 Bn 1.05 Bn 35.09%
3 Elanco Animal Health 11.77 Bn 11.24 Bn 798.00 Mn 3.95%
4 Phibro Animal Health 1.49 Bn 1.41 Bn 134.40 Mn 5.47%
5 Immucell 90.19 Mn 81.33 Mn 2.44 Mn 25.53%
6 Zhengye Biotechnology Holding 76.23 Mn 69.14 Mn - -
7 Global Innovative Platforms 24.88 Mn 24.63 Mn - -476.55%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.53%
Dec 31, 2025 -34.38%
Sep 30, 2025 -2.54%
Jun 30, 2025 7.79%
Mar 31, 2025 17.94%
Dec 31, 2024 12.58%
Sep 30, 2024 -11.67%
Jun 30, 2024 -27.99%
Mar 31, 2024 -6.03%
Sep 30, 2023 -17.42%
Jun 30, 2023 -39.06%
Mar 31, 2023 -67.17%
Dec 31, 2022 -29.10%
Sep 30, 2022 -13.66%
Jun 30, 2022 -24.81%
Mar 31, 2022 12.26%
Dec 31, 2021 1.80%
Sep 30, 2021 2.87%
Jun 30, 2021 3.11%
Mar 31, 2021 -10.74%